首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1724760

數位病理學：技術與全球市場

Digital Pathology: Technologies and Global Markets

出版日期: 2025年04月29日 | 出版商:

BCC Research | 英文 170 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球數位病理學市場規模預計將從 2024 年的 78 億美元成長到 2029 年底的 137 億美元，在 2024-2029 年預測期內的複合年成長率為 11.9%。

預計北美市場將從 2024 年的 33 億美元擴大到 2029 年的 60 億美元，同期的複合年成長率為 12.4%。預計歐洲市場將從 2024 年的 22 億美元成長到 2029 年的 35 億美元，預測期內的複合年成長率為 10.2%。

本報告調查了全球數位病理學市場，並提供了全面的市場概述、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

概述
驅動程式
成本效益推動數位病理學的擴展
擴大數位病理學的應用以提高實驗室效率
癌症發生率增加
增加對數位病理學的投資和資金
限制因素
工作流程整合挑戰
資源有限的國家採用緩慢
機會
數位病理學中的人工智慧
技術進步
任務
病理學家的短缺和分配不均
資料管理
數位病理學的最新趨勢
合作開發更好的解決方案
創新推動市場成長
透過雲端運算加強醫療保健服務
數字和計算病理學

第4章監管情況

法規環境
美國
歐洲

第5章市場區隔分析

細分市場
概述
市場分析：按系統
數位IVD設備
數位病理設備
數位病理分析
數位病理通訊平台
數位病理儲存平台
遠端病理學系統
按類型進行市場分析
數位血液學和臨床病理學
數位解剖病理學
數位微生物
數位遺傳病理學
數位免疫病理學
數位化學病理學
數位法醫學病理學
市場分析：按應用
疾病診斷
藥物研發
研發及其他
最終用戶的市場分析
醫院和診斷中心
生物技術和製藥公司
學術中心等
地理分佈
市場分析：按地區
北美洲
歐洲
亞太地區
其他地區

第6章新興趨勢與技術

概述
連接複用技術的進展
分子病理學進展
高光譜遙測和頻譜成像
空間生物標記整合
整個幻燈片的數位影像
雲端運算與數位病理學
數位病理學中的人工智慧
2024年數位病理學的人工智慧進展

第7章 ESG趨勢

ESG：簡介
主要製造商在數位病理學市場的 ESG永續性
ESG風險評估
BCC 的觀點

第8章專利分析

第9章競爭態勢

併購/合作
企業市場占有率分析
其他關鍵策略

第10章附錄

調查方法
來源
簡稱
公司簡介
3DHISTECH LTD.
APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.
CORISTA
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS LLC.
KONINKLIJKE PHILIPS NV
LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
VISIOPHARM A/S
XIFIN INC.

簡介目錄圖表

Product Code: HLC161E

The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.

The North American digital pathology market is expected to grow from $3.3 billion in 2024 and is projected to reach $6.0 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

The European digital pathology market is expected to grow from $2.2 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 10.2% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the digital pathology market, providing forecasted trends and sales projections for this market through 2029. It covers key market players, product segments, supporting technologies, emerging trends, competitive intelligence, major geographies and their competitive landscapes, and it offers regional insights. The report's in-depth analysis of market dynamics and their impact(s) forms the foundation for its qualitative assessments and market estimates.

Digital pathology is the process of converting glass slide samples into digital images to enable electronic analysis, storage and sharing. This conversion, which enhances diagnostic accuracy, collaboration and efficiency by facilitating advanced imaging, computational analysis and telepathology, has revolutionized pathology with data-driven insights and remote consultations.

While this report outlines the conventional processes of pathology laboratories, it does not include market analysis for traditional lab devices such as microscopes and slides. The connectivity and network issues discussed are specific to data and information related to pathology lab diagnoses, excluding broader hospital-based mHealth (Mobile Health) concerns. This report's coverage of telepathology is focused on diagnostic applications, research and development (R&D), and education and training but does not address telemedicine at a broader level.

This report addresses regulatory aspects, including innovations; technological advances (patents and approvals); and the latest trends, preferences and developments in digital pathology. As part of its analysis, it segments the digital pathology market by system, type, application and end user. The market has also been segmented into the following major geographies, North America, Asia-Pacific, Europe and the Rest of the World, and there is focused coverage of countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Includes

91 data tables and 57 additional tables
An analysis of the global market for digital pathology technologies
Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Descriptions of the upcoming market opportunities for the digital pathology market, factors driving its growth, and forecasts for this market's segments and sub-segments
Estimates of the market size and forecasts for the digital pathology market in value (USD millions) terms, and a corresponding market share analysis by system, type, application, end user and geographic region
In-depth information regarding major market dynamics, technology updates, new products and applications, and COVID-19's impact on the market for digital pathology
Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2029
Information on mergers and acquisitions, agreements, collaborations and product launches in the digital pathology industry
Analysis of relevant patents
A discussion of the industry's ESG challenges and practices
Analysis of the competitive landscape for digital pathology companies, and a value share analysis based on their segmental revenues and financial performance
Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Nikon Instruments Inc., Danaher Corp., and Indica Labs Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Market Overview
Historical Development of Digital Pathology
Conventional Process Versus Digital Pathology

Chapter 3 Market Dynamics

Overview
Drivers
Cost-Effectiveness Drives Digital Pathology Expansion
Growing Adoption of Digital Pathology to Enhance Lab Efficiency
Increasing Incidence of Cancer
Increasing Investments and Funding in Digital Pathology
Restraints
Workflow Integration
Slow Implementation of Digital Pathology in Low-Resource Countries
Opportunities
AI in Digital Pathology
Technology Advances
Challenges
Shortage and Unequal Distribution of Pathologists
Data Management
Current Trends in Digital Pathology
Collaborations to Develop Better Solutions
Innovations to Drive Market Growth
Cloud Computing to Enhance Healthcare Delivery Systems
Digital and Computational Pathology

Chapter 4 Regulatory Landscape

Regulatory Environment
U.S.
Europe

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Overview
Market Analysis by System
Digital IVD devices
Digital Pathology Devices
Digital Pathology Analytics
Digital Pathology Communication Platform
Digital Pathology Storage Platform
Telepathology Systems
Market Analysis by Type
Digital Hematology and Clinical Pathology
Digital Anatomical Pathology
Digital Microbiology
Digital Genetic Pathology
Digital Immunopathology
Digital Chemical Pathology
Digital Forensic Pathology
Market Analysis by Application
Disease Diagnosis
Drug Discovery and Development
R&D and Others
Market Analysis by End User
Hospitals and Diagnostic Centers
Biotech and Pharma Companies
Academic Centers and Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World

Chapter 6 Emerging Trends and Technologies

Overview
Advances in Multiplexing Methods
Advancing Molecular Pathology
Hyperspectral and Multispectral Imaging
Spatial Biomarker Integration
Whole Slide Digital Imaging
Cloud Computing and Digital Pathology
AI in Digital Pathology
Advances in AI in Digital Pathology in 2024

Chapter 7 ESG Developments

Introduction to ESG
ESG Sustainability in Digital Pathology Market, by Major Manufacturers
ESG Risk Ratings
BCC Research Viewpoint

Chapter 8 Patent Analysis

Overview
Digital Pathology

Chapter 9 Competitive Landscape

Mergers, Acquisitions and Collaborations
Company Share Analysis
Other Key Strategies

Chapter 10 Appendix

Methodology
Sources
Abbreviations
Company Profiles
3DHISTECH LTD.
APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.
CORISTA
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS LLC.
KONINKLIJKE PHILIPS N.V.
LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
VISIOPHARM A/S
XIFIN INC.
Emerging Start-ups/Market Disrupters

簡介目錄圖表

List of Tables

Summary Table : Global Digital Pathology Market, by Region, Through 2029
Table 1 : Evolution of Pathology: Key Milestones and Technological Advances
Table 2 : Comparison of Traditional Pathology vs. Digital Pathology
Table 3 : Recent Funding for Digital Pathology, 2025
Table 4 : Global Digital Pathology Market, by System, Through 2029
Table 5 : Global Digital Pathology Market, by System, Through 2029
Table 6 : Global Digital IVD Devices Market, by Product, Through 2029
Table 7 : Global Automated Hematology Analyzers and Blood Cell Counters Market, by Region, Through 2029
Table 8 : Global Digital Holographic Microscopy Market, by Region, Through 2029
Table 9 : Global Digital Urine Sediment Analyzers Market, by Region, Through 2029
Table 10 : Global Digital Chromosome Analyzers Market, by Region, Through 2029
Table 11 : Global Immunohistochemistry Image Analysis Applications Market, by Region, Through 2029
Table 12 : Global Digital Polymerase Chain Reaction Market, by Region, Through 2029
Table 13 : Global Digital Cytopathology Market, by Region, Through 2029
Table 14 : Global Digital Cytopathology Market, by Region, Through 2029
Table 15 : Global Signet Cell Detection Market, by Region, Through 2029
Table 16 : Global Digital Pathology Devices Market, by Region, Through 2029
Table 17 : Global Digital Pathology Devices Market, by Type, Through 2029
Table 18 : Global Scanners Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 19 : Global Robotic Microscopes Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 20 : Global Digital Cameras Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 21 : Global Digital Pathology Analytics Market, by Region, Through 2029
Table 22 : Global Digital Pathology Communication Platform Market, by Region, Through 2029
Table 23 : Global Digital Pathology Storage Platform Market, by Region, Through 2029
Table 24 : Global Telepathology Systems Market, by Region, Through 2029
Table 25 : Global Digital Pathology Market, by Type, Through 2029
Table 26 : Global Digital Hematology and Clinical Pathology Market, by Region, Through 2029
Table 27 : Global Digital Anatomic Pathology Market, by Region, Through 2029
Table 28 : Global Digital Microbiology Market, by Region, Through 2029
Table 29 : Global Digital Genetic Pathology Market, by Region, Through 2029
Table 30 : Global Digital Immunopathology Market, by Region, Through 2029
Table 31 : Global Digital Chemical Pathology Market, by Region, Through 2029
Table 32 : Global Digital Forensic Pathology Market, by Region, Through 2029
Table 33 : Global Digital Pathology Market, by Application, Through 2029
Table 34 : Global Digital Pathology Disease Diagnosis Market, by Region, Through 2029
Table 35 : Global Digital Pathology Drug Discovery and Development Market, by Region, Through 2029
Table 36 : R&D Expenditures in the Global Pharmaceutical Industry, by Leading 19 Companies, 2023
Table 37 : Global Digital Pathology R&D and Others Market, by Region, Through 2029
Table 38 : Global Digital Pathology Market, by End User, Through 2029
Table 39 : Global Digital Pathology Market in Hospitals and Diagnostic Centers, by Region, Through 2029
Table 40 : Global Digital Pathology Market in Biotech and Pharmaceutical Companies, by Region, Through 2029
Table 41 : Global Digital Pathology Market in Academic Centers and Other End-Users, by Region, Through 2029
Table 42 : Global Digital Pathology Market, by Region, Through 2029
Table 43 : North American Digital Pathology Market, by Country, Through 2029
Table 44 : North American Digital Pathology Market, by System, Through 2029
Table 45 : North American Digital Pathology Market, by Type, Through 2029
Table 46 : North American Digital Pathology Market, by Application, Through 2029
Table 47 : North American Digital Pathology Market, by End User, Through 2029
Table 48 : U.S. Digital Pathology Market, by System, Through 2029
Table 49 : U.S. Digital Pathology Market, by Type, Through 2029
Table 50 : Canadian Digital Pathology Market, by System, Through 2029
Table 51 : Canadian Digital Pathology Market, by Type, Through 2029
Table 52 : Mexican Digital Pathology Market, by System, Through 2029
Table 53 : Mexican Digital Pathology Market, by Type, Through 2029
Table 54 : European Digital Pathology Market, by Country, Through 2029
Table 55 : European Digital Pathology Market, by System, Through 2029
Table 56 : European Digital Pathology Market, by Type, Through 2029
Table 57 : European Digital Pathology Market, by Application, Through 2029
Table 58 : European Digital Pathology Market, by End User, Through 2029
Table 59 : U.K. Digital Pathology Market, by System, Through 2029
Table 60 : U.K. Digital Pathology Market, by Type, Through 2029
Table 61 : French Digital Pathology Market, by System, Through 2029
Table 62 : French Digital Pathology Market, by Type, Through 2029
Table 63 : Italian Digital Pathology Market, by System, Through 2029
Table 64 : Italian Digital Pathology Market, by Type, Through 2029
Table 65 : German Digital Pathology Market, by System, Through 2029
Table 66 : German Digital Pathology Market, by Type, Through 2029
Table 67 : Spanish Digital Pathology Market, by System, Through 2029
Table 68 : Spanish Digital Pathology Market, by Type, Through 2029
Table 69 : Rest of the European Digital Pathology Market, by System, Through 2029
Table 70 : Rest of the European Digital Pathology Market, by Type, Through 2029
Table 71 : Asia-Pacific Digital Pathology Market, by Country, Through 2029
Table 72 : Asia-Pacific Digital Pathology Market, by System, Through 2029
Table 73 : Asia-Pacific Digital Pathology Market, by Type, Through 2029
Table 74 : Asia-Pacific Digital Pathology Market, by Application, Through 2029
Table 75 : Asia-Pacific Digital Pathology Market, by End User, Through 2029
Table 76 : Chinese Digital Pathology Market, by System, Through 2029
Table 77 : Chinese Digital Pathology Market, by Type, Through 2029
Table 78 : Indian Digital Pathology Market, by System, Through 2029
Table 79 : Indian Digital Pathology Market, by Type, Through 2029
Table 80 : Japanese Digital Pathology Market, by System, Through 2029
Table 81 : Japanese Digital Pathology Market, by Type, Through 2029
Table 82 : Australian Digital Pathology Market, by System, Through 2029
Table 83 : Australian Digital Pathology Market, by Type, Through 2029
Table 84 : South Korean Digital Pathology Market, by System, Through 2029
Table 85 : South Korean Digital Pathology Market, by Type, Through 2029
Table 86 : Rest of Asia-Pacific Digital Pathology Market, by System, Through 2029
Table 87 : Rest of Asia-Pacific Digital Pathology Market, by Type, Through 2029
Table 88 : Rest of the World Digital Pathology Market, by System, Through 2029
Table 89 : Rest of the World Digital Pathology Market, by Type, Through 2029
Table 90 : Rest of the World Digital Pathology Market, by Application, Through 2029
Table 91 : Rest of the World Digital Pathology Market, by End User, Through 2029
Table 92 : Key Focus Areas in Environmental Sustainability
Table 93 : ESG Highlights, by Major Players, 2023
Table 94 : ESG Risk Rankings for Digital Pathology Solutions Manufacturing Companies, 2023
Table 95 : Mergers and Acquisitions in Digital Pathology Market, 2021-2024
Table 96 : New Product Launches in the Digital Pathology Market, 2021-2024
Table 97 : Other Key Strategies in the Digital Pathology Market, 2022-2025
Table 98 : Information Sources in this Report
Table 99 : Major Abbreviations Used in This Report
Table 100 : 3DHISTECH Ltd.: Company Snapshot
Table 101 : 3DHISTECH Ltd.: Product Portfolio
Table 102 : 3DHISTECH Ltd.: Recent Developments, 2021-2024
Table 103 : Apollo Enterprise Imaging Corp.: Company Snapshot
Table 104 : Apollo Enterprise Imaging Corp.: Product Portfolio
Table 105 : Apollo Enterprise Imaging Corp.: Recent Developments, 2022-2024
Table 106 : Clinisys Inc.: Company Snapshot
Table 107 : CliniSys Inc.: Product Portfolio
Table 108 : CliniSys Inc.: Recent Developments, 2021-2024
Table 109 : Corista: Company Snapshot
Table 110 : Corista: Product Portfolio
Table 111 : Corista: Recent Developments, 2022-2024
Table 112 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 113 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 114 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 115 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021-2024
Table 116 : Fujifilm Holdings Corp.: Company Snapshot
Table 117 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 118 : Fujifilm Holdings Corp.: Product Portfolio
Table 119 : Fujifilm Holdings Corp.: News/Key Developments, 2021-2024
Table 120 : Huron Technologies International Inc.: Company Snapshot
Table 121 : Huron Technologies International Inc.: Product Portfolio
Table 122 : Huron Technologies International Inc.: Recent Developments, 2021-2023
Table 123 : Indica Labs LLC.: Company Snapshot
Table 124 : Indica Labs LLC.: Product Portfolio
Table 125 : Indica Labs LLC.: Recent Developments, 2022-2025
Table 126 : Koninklijke Philips N.V.: Company Snapshot
Table 127 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 128 : Koninklijke Philips N.V.: Product Portfolio
Table 129 : Koninklijke Philips N.V.: News/Key Developments, 2021-2024
Table 130 : Leica Biosystems Nussloch GmbH.: Company Snapshot
Table 131 : Leica Biosystems Nussloch GmbH: Product Portfolio
Table 132 : Leica Biosystems Nussloch GmbH: Recent Developments, 2021-2025
Table 133 : LigoLab Information Systems: Company Snapshot
Table 134 : LigoLab Information Systems: Product Portfolio
Table 135 : Mikroscan Technologies Inc.: Company Snapshot
Table 136 : Mikroscan Technologies Inc.: Product Portfolio
Table 137 : Mikroscan Technologies Inc.: Recent Developments, 2021 and 2024
Table 138 : Nikon Instruments Inc.: Company Snapshot
Table 139 : Nikon Instruments Inc.: Product Portfolio
Table 140 : Nikon Instruments Inc.: Recent Developments, 2021-2024
Table 141 : Visiopharm A/S: Company Snapshot
Table 142 : Visiopharm A/S: Product Portfolio
Table 143 : Visiopharm A/S: Recent Developments, 2021-2024
Table 144 : XIFIN Inc.: Company Snapshot
Table 145 : XIFIN Inc.: Product Portfolio
Table 146 : XIFIN Inc.: Recent Developments, 2021-2022
Table 147 : List of Few Emerging Startups

List of Figures

Summary Figure : Global Digital Pathology Market Shares, by Region, 2023
Figure 1 : Digital Pathology Adopters, 2025
Figure 2 : Snapshot of Market Dynamics
Figure 3 : Global Shares of Cancer Incidence (New) Cases, by WHO Region, 2022
Figure 4 : Global Shares of Cancer Mortality Cases, by WHO Region, 2022
Figure 5 : U.S. Digital Health Funding and Number of Deals, 2012-2022
Figure 6 : Distribution of Pathologists, by Continent, 2019-2022
Figure 7 : Global Digital Pathology Market Shares, by System, 2023
Figure 8 : Global Digital Pathology Market Shares, by Type, 2023
Figure 9 : Global Digital Pathology Market Shares, by Application, 2023
Figure 10 : Global Digital Pathology Market Shares, by End User, 2023
Figure 11 : Global Digital Pathology Market Shares, by Region, 2023
Figure 12 : 2024 Progress Assessment: Tracking the Sustainable Development Goals
Figure 13 : Patents Documented, by Top Owners, 2021-2024
Figure 14 : Share of Patents Documented, by Jurisdiction, 2021-2024
Figure 15 : Patents Documented Over Time, 2010-November 2024
Figure 16 : Shares of Global Market for Medical Imaging, by Leading Manufacturers, 2023
Figure 17 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 18 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 19 : Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 22 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023